Extraction of pharmacokinetic evidence of drug-drug interactions from the literature

dc.contributor.authorKolchinsky, Artemy
dc.contributor.authorLourenço, Anália
dc.contributor.authorWu, Heng-Yi
dc.contributor.authorLi, Lang
dc.contributor.authorRocha, Luis M.
dc.contributor.departmentDepartment of Medical and Molecular Genetics, IU School of Medicineen_US
dc.date.accessioned2016-06-17T17:58:32Z
dc.date.available2016-06-17T17:58:32Z
dc.date.issued2015-05-11
dc.description.abstractDrug-drug interaction (DDI) is a major cause of morbidity and mortality and a subject of intense scientific interest. Biomedical literature mining can aid DDI research by extracting evidence for large numbers of potential interactions from published literature and clinical databases. Though DDI is investigated in domains ranging in scale from intracellular biochemistry to human populations, literature mining has not been used to extract specific types of experimental evidence, which are reported differently for distinct experimental goals. We focus on pharmacokinetic evidence for DDI, essential for identifying causal mechanisms of putative interactions and as input for further pharmacological and pharmacoepidemiology investigations. We used manually curated corpora of PubMed abstracts and annotated sentences to evaluate the efficacy of literature mining on two tasks: first, identifying PubMed abstracts containing pharmacokinetic evidence of DDIs; second, extracting sentences containing such evidence from abstracts. We implemented a text mining pipeline and evaluated it using several linear classifiers and a variety of feature transforms. The most important textual features in the abstract and sentence classification tasks were analyzed. We also investigated the performance benefits of using features derived from PubMed metadata fields, various publicly available named entity recognizers, and pharmacokinetic dictionaries. Several classifiers performed very well in distinguishing relevant and irrelevant abstracts (reaching F1≈0.93, MCC≈0.74, iAUC≈0.99) and sentences (F1≈0.76, MCC≈0.65, iAUC≈0.83). We found that word bigram features were important for achieving optimal classifier performance and that features derived from Medical Subject Headings (MeSH) terms significantly improved abstract classification. We also found that some drug-related named entity recognition tools and dictionaries led to slight but significant improvements, especially in classification of evidence sentences. Based on our thorough analysis of classifiers and feature transforms and the high classification performance achieved, we demonstrate that literature mining can aid DDI discovery by supporting automatic extraction of specific types of experimental evidence.en_US
dc.identifier.citationKolchinsky, A., Lourenço, A., Wu, H.-Y., Li, L., & Rocha, L. M. (2015). Extraction of Pharmacokinetic Evidence of Drug–Drug Interactions from the Literature. PLoS ONE, 10(5), e0122199. http://doi.org/10.1371/journal.pone.0122199en_US
dc.identifier.urihttps://hdl.handle.net/1805/10028
dc.language.isoen_USen_US
dc.publisherPLoSen_US
dc.relation.isversionof10.1371/journal.pone.0122199en_US
dc.relation.journalPLoS ONEen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectData Miningen_US
dc.subjectDrug Interactionsen_US
dc.subjectHumansen_US
dc.subjectMedical Subject Headingsen_US
dc.subjectNatural Language Processingen_US
dc.subjectPharmacokineticsen_US
dc.subjectPubMeden_US
dc.titleExtraction of pharmacokinetic evidence of drug-drug interactions from the literatureen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
pone.0122199.pdf
Size:
1.67 MB
Format:
Adobe Portable Document Format
Description:
Main Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description: